Over 80 professionals with one goal: protecting your IP

Our focus on patents, trade marks and other intellectual property means that we offer our clients an unparalleled depth of knowledge and a complete suite of IP services.

Why it matters »

Stay informed

Sign up for our quarterly IP Update e-Mag and keep on top of the latest IP news and cases.

Read the lastest issue »
See past issues »

Federal Court: trade mark licence restraints can be wider than Trade Marks Act deceptive similarity

By and | Monday, May 23, 2011

Symbion Pharmacy Services Pty Ltd v Idameneo (No. 789) Limited [2011] FCA 389

The Federal Court has held that a contractual restraint prohibiting the respondent-licensee from using a mark similar to or capable of being confused with the licensed mark had a wider effect than what constituted infringement under the Trade Marks Act.  The Court, however, dismissed the applicant's claim for trade mark infringement on the basis that it did not call evidence about the likelihood of the respondent's mark to deceive or cause confusion in the "specialised market" (radiology services) in which that mark was used.

This case demonstrates, among other things, that parties to a trade mark licence or assignment need to be diligent in ensuring that they understand the full implications of the licence or assignment document, including any restraints that may be imposed upon them, and the meaning of terms that are expressly included in the document, before they enter into it.

On 24 May 2011, Jessup J ordered that Idameneo 789 be permanently restrained from using the Idameneo 789 Mark.  

For a more in-depth analysis of the Court's reasoning, and a discussion of the practical implications of this case, please see the upcoming June 2011 edition of IP Update.


Filed under: Legal briefing Trade Marks IP Law Commercialisation Medical technology Pharmaceuticals